International Patent: NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF INHBE IN A CELL

GENEVA, July 2 -- SILENCE THERAPEUTICS GMBH filed a patent application (EP2025/088214) for “NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF INHBE IN A CELL”. With publication no. WO/2026/132332, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....